Категории

Akebia Therapeutics' CEO on Mechanisms of HIF-PHI Candidate

Опубликовано: 23 Октябрь 2020
на канале: AJMCtv
1,823
12

Vadadustat is an investigational drug belonging to a class known as hypoxia-inducible prolyl hydroxylase inhibitors (HIF-PHIs) for the treatment of anemia in chronic kidney disease.

Смотрите видео Akebia Therapeutics' CEO on Mechanisms of HIF-PHI Candidate онлайн без регистрации, длительностью часов минут секунд в хорошем качестве. Это видео добавил пользователь AJMCtv 23 Октябрь 2020, не забудьте поделиться им ссылкой с друзьями и знакомыми, на нашем сайте его посмотрели 1,823 раз и оно понравилось 12 людям.

play_arrow
117
3

IDM 6.32 Build 1 32+64 BIT {FULL ACTIVATED} 100% Working IN HINDI

IDM 6.32 Build 1 32+64 BIT {FULL ACTIVATED} 100% Working IN HINDI
play_arrow
3,208
29

رئيس الدولة في مقدمة مستقبليه.. ملك الأردن يصل البلاد في زيارة دولة

رئيس الدولة في مقدمة مستقبليه.. ملك الأردن يصل البلاد في زيارة دولة
play_arrow
57
0

Subdivision Brain Buster

Subdivision Brain Buster
play_arrow
4,917
15

Sketchup to Unity3d

Sketchup to Unity3d
play_arrow
11,345
177

La princesa Leonor luce uniforme que vistió hace 38 años su padre, el rey Felipe VI | ¡HOLA! TV

La princesa Leonor luce uniforme que vistió hace 38 años su padre, el rey Felipe VI | ¡HOLA! TV
play_arrow
15,983
78

Сборник - Чеченский Супер-хит 2023 | KAVKAZ MUSIC CHECHNYA

Сборник - Чеченский Супер-хит 2023 | KAVKAZ MUSIC CHECHNYA
play_arrow
397,159
3.6 тыс

00:20:04

Ishq Mein Marjawan - Full Episode 397 - With English Subtitles

Ishq Mein Marjawan - Full Episode 397 - With English Subtitles
play_arrow
154
2

Big Data Environment Setup on Windows Part 5: Hive Installation

Big Data Environment Setup on Windows Part 5: Hive Installation
Похожие видео
play_arrow
Dr Mark Fendrick Explains Bipartisan Appeal of Value-Based Insurance Design

Dr Mark Fendrick Explains Bipartisan Appeal of Value-Based Insurance Design
play_arrow
Dr Frank Porreca Talks Through the Challenges of Measuring Migraine Pain

Dr Frank Porreca Talks Through the Challenges of Measuring Migraine Pain
play_arrow
Dr Peter McAllister Shares How COVID-19 Altered Patients' Migraine Symptoms

Dr Peter McAllister Shares How COVID-19 Altered Patients' Migraine Symptoms
play_arrow
Dr Stephen Silberstein Discusses Erenumab Use for Menstrual Migraine

Dr Stephen Silberstein Discusses Erenumab Use for Menstrual Migraine
play_arrow
Dr Ruth Ann Marrie Discusses Comorbidities in Multiple Sclerosis

Dr Ruth Ann Marrie Discusses Comorbidities in Multiple Sclerosis
play_arrow
Dr George Bakris Compares FIDELIO-DKD Renal Outcomes With Those of SGLT-2 Inhibitor Trials

Dr George Bakris Compares FIDELIO-DKD Renal Outcomes With Those of SGLT-2 Inhibitor Trials
play_arrow
Dr Shweta Bansal Explains Factors Associated With Increased Screening, Recognition of CKD

Dr Shweta Bansal Explains Factors Associated With Increased Screening, Recognition of CKD
play_arrow
Dr Joshua Rein Offers Insights on Cannabis Use for Chronic Kidney Disease

Dr Joshua Rein Offers Insights on Cannabis Use for Chronic Kidney Disease
play_arrow
Akebia Therapeutics' CEO on Mechanisms of HIF-PHI Candidate

Akebia Therapeutics' CEO on Mechanisms of HIF-PHI Candidate
play_arrow
Dr Rajiv Agarwal Discusses Finerenone, Results of FIDELIO-DKD

Dr Rajiv Agarwal Discusses Finerenone, Results of FIDELIO-DKD
play_arrow
Dr Timothy Yap Reiterates the Unmet Medical Need for Molecularly Targeted Agents in Solid Tumors

Dr Timothy Yap Reiterates the Unmet Medical Need for Molecularly Targeted Agents in Solid Tumors
play_arrow
Whole-Person Health Care: Integrating Mental and Behavioral Health Into Primary Care

Whole-Person Health Care: Integrating Mental and Behavioral Health Into Primary Care
play_arrow
A Patient Perspective on Early-Onset Parkinson Disease

A Patient Perspective on Early-Onset Parkinson Disease
play_arrow
Dr Stephen Silberstein Compares the Effects of Erenumab on Chronic, Episodic Migraine

Dr Stephen Silberstein Compares the Effects of Erenumab on Chronic, Episodic Migraine
play_arrow
Dr Frank Porreca Discusses New Developments in Migraine Science

Dr Frank Porreca Discusses New Developments in Migraine Science
play_arrow
Dr Andre Goy Discusses What We’ve Learned About CAR T Therapies and Cytokine Responses

Dr Andre Goy Discusses What We’ve Learned About CAR T Therapies and Cytokine Responses
play_arrow
Dr Neal Jain Discusses Type 2 Inflammation in Asthma

Dr Neal Jain Discusses Type 2 Inflammation in Asthma
play_arrow
Dr Kassandra Munger on Vitamin D and Multiple Sclerosis

Dr Kassandra Munger on Vitamin D and Multiple Sclerosis
play_arrow
Dr Timothy Yap: Rucaparib/Sacituzumab Govitecan Combo Effective Against Triple-Negative Disease

Dr Timothy Yap: Rucaparib/Sacituzumab Govitecan Combo Effective Against Triple-Negative Disease
play_arrow
Dr Neal Jain on the Real-World Results of Dupilumab in Asthma

Dr Neal Jain on the Real-World Results of Dupilumab in Asthma
play_arrow
Using SGLT2 Inhibitors to Achieve Cardiovascular Benefits

Using SGLT2 Inhibitors to Achieve Cardiovascular Benefits
play_arrow
Dr Melissa Johnson: Tiragolumab/Atezolizumab Potential New Treatment Option for NSCLC

Dr Melissa Johnson: Tiragolumab/Atezolizumab Potential New Treatment Option for NSCLC
play_arrow
Cost-Effectiveness Data and Pricing of Icosapent Ethyl

Cost-Effectiveness Data and Pricing of Icosapent Ethyl
play_arrow
Dr John McMurray Compares EMPEROR-Reduced Findings with DAPA-HF

Dr John McMurray Compares EMPEROR-Reduced Findings with DAPA-HF